Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fisetin Regulates Gut Microbiota and Exerts Neuroprotective Effect on Mouse Model of Parkinson’s Disease
Tian-Jiao Chen, Ya Feng, Te Liu, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

The neuroprotective effects of fisetin, a natural flavonoid in neurodegenerative diseases: Focus on the role of oxidative stress
Syed Shams ul Hassan, Saptadip Samanta, Raju Dash, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 76
Fisetin, potential flavonoid with multifarious targets for treating neurological disorders: An updated review
Arun Reddy Ravula, Suraj B. Teegala, Kalakotla Shanker, et al.
European Journal of Pharmacology (2021) Vol. 910, pp. 174492-174492
Closed Access | Times Cited: 79
Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson’s disease
Can Cui, Yingying Han, Hongxia Li, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 62
The Interaction of Polyphenols and the Gut Microbiota in Neurodegenerative Diseases
Yuan Zhang, Wanpeng Yu, Lei Zhang, et al.
Nutrients (2022) Vol. 14, Iss. 24, pp. 5373-5373
Open Access | Times Cited: 49
Neuroprotective Effects of Bifidobacterium breve CCFM1067 in MPTP-Induced Mouse Models of Parkinson’s Disease
Tiantian Li, Chuanqi Chu, Leilei Yu, et al.
Nutrients (2022) Vol. 14, Iss. 21, pp. 4678-4678
Open Access | Times Cited: 46
Emerging Interrelationship Between the Gut Microbiome and Cellular Senescence in the Context of Aging and Disease: Perspectives and Therapeutic Opportunities
Rohit Sharma
Probiotics and Antimicrobial Proteins (2022) Vol. 14, Iss. 4, pp. 648-663
Open Access | Times Cited: 45
Dietary (Poly)phenols and the Gut–Brain Axis in Ageing
Léonie Láng, Simon McArthur, Alpár S. Lázár, et al.
Nutrients (2024) Vol. 16, Iss. 10, pp. 1500-1500
Open Access | Times Cited: 12
Anti-Oxidative, Anti-Inflammatory and Anti-Apoptotic Effects of Flavonols: Targeting Nrf2, NF-κB and p53 Pathways in Neurodegeneration
Maja Jazvinšćak Jembrek, Nada Oršolić, Lucija Mandić, et al.
Antioxidants (2021) Vol. 10, Iss. 10, pp. 1628-1628
Open Access | Times Cited: 49
Fisetin Improves Hyperuricemia-Induced Chronic Kidney Disease via Regulating Gut Microbiota-Mediated Tryptophan Metabolism and Aryl Hydrocarbon Receptor Activation
Qian Ren, Lu Cheng, Fan Guo, et al.
Journal of Agricultural and Food Chemistry (2021) Vol. 69, Iss. 37, pp. 10932-10942
Closed Access | Times Cited: 42
Human Umbilical Cord Mesenchymal Stem Cells Improve Locomotor Function in Parkinson’s Disease Mouse Model Through Regulating Intestinal Microorganisms
Z. Sun, Ping Gu, Hongjun Xu, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 36
Harnessing the therapeutic potential of fisetin and its nanoparticles: Journey so far and road ahead
Sukriti Vishwas, Sachin Kumar Singh, Monica Gulati, et al.
Chemico-Biological Interactions (2022) Vol. 356, pp. 109869-109869
Closed Access | Times Cited: 33
Effects of Fisetin, a Plant-Derived Flavonoid, on Response to Oxidative Stress, Aging, and Age-Related Diseases in Caenorhabditis elegans
Su-Hyeon Park, Bo-Kyoung Kim, Sang-Kyu Park
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1528-1528
Open Access | Times Cited: 27
The Neuroprotective Role of Fisetin in Different Neurological Diseases: a Systematic Review
Yizhen Jiang, Xiangwen Tang, Peng Deng, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 11, pp. 6383-6394
Closed Access | Times Cited: 15
Therapeutic Potential and Molecular Mechanisms of the Multitargeted Flavonoid Fisetin
Abdur Rauf, Tareq Abu‐Izneid, Muhammad Imran, et al.
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 21, pp. 2075-2096
Closed Access | Times Cited: 14
Nurturing longevity through natural compounds: Where do we stand, and where do we go?
Monika N. Todorova, Martina S. Savova, Liliya V. Vasileva, et al.
Food Frontiers (2024) Vol. 5, Iss. 2, pp. 267-310
Open Access | Times Cited: 5
Fisetin-loaded chitosan nanoparticles ameliorate pilocarpine-induced temporal lobe epilepsy and associated neurobehavioral alterations in mice: Role of ROS/TNF-α-NLRP3 inflammasomes pathway
Sagar Mahawar, Debarati Rakshit, Inklisan Patel, et al.
Nanomedicine Nanotechnology Biology and Medicine (2024) Vol. 59, pp. 102752-102752
Closed Access | Times Cited: 5
Modulatory Effects of Phytochemicals on Gut–Brain Axis: Therapeutic Implication
Khojasteh Rahimi Jaberi, Vahab Alamdari-Palangi, Amir Savardashtaki, et al.
Current Developments in Nutrition (2024) Vol. 8, Iss. 6, pp. 103785-103785
Open Access | Times Cited: 5
Fisetin Promotes Functional Recovery after Spinal Cord Injury by Inhibiting Microglia/Macrophage M1 Polarization and JAK2/STAT3 Signaling Pathway
Rong Ji, Zhizhong Hao, Hao Wang, et al.
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 32, pp. 17964-17976
Closed Access | Times Cited: 5
Convergence of Neuroinflammation, Microbiota, and Parkinson’s Disease: Therapeutic Insights and Prospects
Nerea Domínguez Rojo, Mercedes Blanco Benítez, Ramón Cava, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11629-11629
Open Access | Times Cited: 4
Integrating Ethnobotany, Phytochemistry, and Pharmacology of Cotinus coggygria and Toxicodendron vernicifluum: What Predictions can be Made for the European Smoketree?
Diana Antal, Florina Ardelean, Alex-Robert Jîjie, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 24
Antiparkinsonian effects of polyphenols: A narrative review with a focus on the modulation of the gut-brain axis
Wei Zhang, Xiaoyu Dong, Rui Huang
Pharmacological Research (2023) Vol. 193, pp. 106787-106787
Open Access | Times Cited: 10
The Interaction Between Nutraceuticals and Gut Microbiota: a Novel Therapeutic Approach to Prevent and Treatment Parkinson’s Disease
Liyan Yao, Yong Yang, Xiaowei Yang, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 11, pp. 9078-9109
Closed Access | Times Cited: 3
Crosstalk between gut–brain axis: unveiling the mysteries of gut ROS in progression of Parkinson’s disease
Divya Soni, Shubham Upadhayay, Maanvi Dhureja, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 5, pp. 2921-2941
Closed Access | Times Cited: 3
Advances in Neuropathic Pain Research: Selected Intracellular Factors as Potential Targets for Multidirectional Analgesics
Katarzyna Ciapała, Joanna Mika
Pharmaceuticals (2023) Vol. 16, Iss. 11, pp. 1624-1624
Open Access | Times Cited: 8
Promising biomarkers and therapeutic targets for the management of Parkinson's disease: recent advancements and contemporary research
Mohammad Ahmed Khan, Nafis Haider, Tanveer Singh, et al.
Metabolic Brain Disease (2023) Vol. 38, Iss. 3, pp. 873-919
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top